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Abstract
Background: Elephants are classified as critically endangered animals by the International Union for Conservation
of Species (IUCN). Elephant endotheliotropic herpesvirus (EEHV) poses a large threat to breeding programs of
captive Asian elephants by causing fatal haemorrhagic disease. EEHV infection is detected by PCR in samples from
both clinically ill and asymptomatic elephants with an active infection, whereas latent carriers can be distinguished
exclusively via serological assays. To date, identification of latent carriers has been challenging, since there are no
serological assays capable of detecting seropositive elephants.
Results: Here we describe a novel ELISA that specifically detects EEHV antibodies circulating in Asian elephant
plasma/serum. Approximately 80 % of PCR positive elephants display EEHV-specific antibodies. Monitoring three
Asian elephant herds from European zoos revealed that the serostatus of elephants within a herd varied from non-
detectable to high titers. The antibody titers showed typical herpes-like rise-and-fall patterns in time which occur in
all seropositive animals in the herd more or less simultaneously.
Conclusions: This study shows that the developed ELISA is suitable to detect antibodies specific to EEHV. It allows
study of EEHV seroprevalence in Asian elephants. Results confirm that EEHV prevalence among Asian elephants
(whether captive-born or wild-caught) is high.
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Background
The family Herpesviridae comprises a diverse group of
viruses, which are divided into three subfamilies (α-,
β- and γ-herpesviridae) [1]. Most commonly, herpesvirus
infection presents as a benign, self-limiting disease with
a mild viraemia. Herpesvirus rarely causes widespread
disseminated disease in the natural host, although cross-
species transmission to non-reservoir hosts can also re-
sult in lethal infections [2]. In general neonates and
immune-compromised hosts are at higher risk of devel-
oping a fatal herpesvirus infection [3, 4].
The elephant endotheliotropic herpesvirus (EEHV) is a
poorly characterized virus of elephants that was first
observed in healthy wild African elephants (Loxodonta
africana) by McCully et al. [5] in 1971 and subsequently
in Asian elephants (Elephas maximus) with no apparent
disease [6]. In 1990 the death of a 3-year old female
Asian circus elephant was associated with herpesvirus by
Ossent et al. [7]. Pathologic changes in the capillary
endothelial cells with herpetic inclusion bodies and weak
cross-neutralization in serum neutralization tests with
bovine herpesviruses suggested that the etiologic agent
was a hitherto unidentified herpesvirus [8, 9], which was
identified in 1999 [10]. The disease has a sudden onset
characterized by lethargy, oral ulcerations, edema in the
skin of the head and proboscis, cyanosis of the tongue,
decreased white blood cell and platelet count and massive
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internal hemorrhages, which lead to death within 12–72 h
after onset of the symptoms. Phylogenetic analysis showed
that EEHV is a distinct branch within the β-herpesviridae
group, assigned as the new genus Proboscivirus [11, 12]. To
date, as many as seven different genotypes of EEHV have
been identified within this genus [13]. However, xtensive
evaluation of several subtypes indicated that EEHVs have a
large genomic inversion of a 40-kb core segment that is dis-
tinct from the Roseoloviruses and all other β-herpesviruses.
Furthermore, they encode α-herpesvirus-like genes that are
absent in β-herpesviruses and contain 60 novel open read-
ing frames not found in any other herpesvirus [12, 14].
These findings suggest that this particular virus is so differ-
ent from other herpesviruses that it may be considered as a
new herpesvirus subfamily [12, 13].
EEHV poses a threat to the conservation mission of
zoos. Several studies have shown that DNAemia can be
detected in Asian elephants before the onset of clinical
signs and in elephants that do not display clinical signs
using PCR techniques [15–19]. To date, this is the only
option to monitor a complete herd, and only allows iden-
tification of animals with an active infection. Therefore,
the detection of antibodies against EEHV likely offers a
better strategy to determine which animals are carriers of
EEHV. Ideally, antibody detection against the whole virus
is preferable, but since the virus cannot be cultured in
vitro, the best alternative is to use an immunodominant
protein, such as glycoprotein B (gB), as an antigen. The
viral envelope protein glycoprotein B of herpesviruses is
involved in host cell entry and represents an important
target of neutralizing antibodies in the host [20, 21]. In
this study a serologic test based on the EEHV-gB antigen
is described. This assay was used to assess seroprevalence
against EEHV-gB in serum and heparin plasma samples
from two large cohorts of European and North-American
captive Asian elephants. These data are useful to link sero-
prevalence with EEHV virus detection by PCR methods
and, at the end, may give better insight into EEHV dynam-
ics within elephant populations.
Methods
Cloning, expression and large scale production of
glycoprotein B
The viral sequence of EEHV-1A glycoprotein B [GenBank:
AF411189] [22] comprising the start codon up to the
transmembrane domain was synthesized (BaseClear, The
Netherlands) and cloned, using XhoI/PstI restriction sites,
into the multiple cloning site in frame with a C-terminal
myc/6His tag, but in an alternative open reading frame
(ORF) relative to the Shine Dalgarno ribosomal binding
site, of the bacterial expression vector pTrcHis2A (Invitro-
gen). Induction of recombinant glycoprotein B expression
was performed in E.coli Rosetta2(DE3)pLysS codon plus
strain (Millipore). This strain supplies tRNAs for 7 rare
codons (AGA, AGG, AUA, CUA, GGA, CCC, and CG
G) in order to improve the expression of heterologous
proteins.
A single colony transformed with the pTrcHis2A-gBmyc/
his plasmid was inoculated into fresh LB medium contain-
ing 100 μg/ml ampicillin and 50 μg/ml chloramphenicol
and grown overnight at 37 °C in a shaker incubator. The
next day 2 l fresh LB medium without antibiotics was inoc-
ulated 1 in 100 with the pre-culture and grown in a shaker
incubator at 37 °C to an OD600 ~ 0.6. The recombinant pro-
tein expression was induced by adding IPTG to an end
concentration of 1 mM. The temperature was lowered to
25 °C for optimal recombinant protein expression.
Cells were harvested 4 h after induction and pelleted
at 6000xG for 10 min in a Beckman Highspeed centri-
fuge using the JLA16.250 rotor. The supernatant was
decanted and the cells were resuspended in native lysis-
buffer (500 mM of NaCl, 50 mM phosphatebuffer
(pH 8.0), 5 % v/v glycerol and 10 mM of Imidazole and
protease inhibitors). Lysozyme was added to an end con-
centration of 1 mM and the cells were treated 30 min at
4 °C at continuous agitation. The cells were cracked by
three freeze/thaw cycles and sonification with a microtip;
8 x 30s at 60 % on ice (Sonopulse HD2070, Bandelin,
Germany). The lysate was cleared by ultracentrifugation
for 2 h at 27.000 rpm in a Beckman Optima L-90 K
ultracentrifuge using the SW32Ti rotor. A similar pro-
cedure was conducted with another pTrcHis2A vector
encoding a 27 kD irrelevant 6His-tagged protein that
was used as a negative control.
Purification of glycoprotein B
The cleared lysate was loaded onto Ni-NTA resin
(Superflow, IBA) which was preconditioned with water
and 1x native lysisbuffer. Binding was performed over-
night at +4 °C under continuous agitation. Next day, the
resin was settled vertically and washed with 6 bed vol-
umes of lysisbuffer containing 20 mM of Imidazole.
Thereafter, the bound recombinant protein was eluted
with 4 bed volumes of elution buffer (500 mM of NaCl,
50 mM phosphate buffer (pH 8.0), 5 % v/v glycerol and
300 mM of Imidazole). Subsequently, salts were re-
moved by dialysis in a Slide-a-Lyzer cassette (3,500
MWCO, 3–12 ml capacity, ThermoScientific) for 48 h at
+4 °C. The dialysis buffer (PBS complemented with
0.1 M NaCl and 5 % v/v glycerol) was refreshed three
times. After dialysis the recombinant protein content was
analyzed for protein concentration (BCA assay, Thermo-
Scientific) and Western Blot. A second round of purifica-
tion was performed by fast protein liquid chromatography
(FPLC) with a 1 ml volume HisTrap-HPTM column (GE
Health Care life sciences) with a pressure flow of 0.15 ml/
min. The his-tagged proteins were eluted from the column
with 10 column volumes (CV) of a linear gradient ranging
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from 50 mM Imidazole up to 500 mM Imidazole in 0.5 ml
aliquots. These were analyzed by Western blot and the elu-
ates containing the his-tagged proteins were subsequently
pooled and dialyzed as described above.
Rabbit anti-EEHV glycoprotein B serum
Five peptide sequences (QDLTVTVSTKKKTF, YNGQNN
KKFSEPSTK, VLDTDSDKKNYSYMS, ANVTSRRRKRDA
NTA and EPSTKFKVYKDYERLQ) derived from the amino
acid sequence of glycoprotein B of EEHV1A [GenBank:
AF411189] were synthesized and coupled to LPH (Limulus
polyphemus hemocyanin) carrier protein. Ten rabbits
(n = 2 Zimmerman rabbits/peptide) were immunized
six times intramuscularly with 10 μg of the respective
peptides. Final bleeding was at day 133 after the first
vaccination. The polyclonal rabbit sera were produced by
Biogenes GmbH (Germany) according to European law on
animal welfare. All rabbit sera were highly reactive against
the respective peptide as tested in a peptide ELISA assay.
Immunodetection of recombinant glycoprotein B
Recombinant glycoprotein B antigen was analyzed by
separation of small samples from the purification
process on a 10 % SDS-PAGE gel (BioRad Laboratories)
and separated products were subsequently transferred to
PVDF membrane (Immobilon, Millipore). Gels were run
in duplicate; one was Coomassie Blue stained for total
protein and the duplicate was analyzed with Western
Table 1 Age, sex, and clinical status of elephants in the study cohort of European zoos
Zoo Animal Sex Born Status Age Serostatus Sample # Period PCR detection Detection
site
Clinical signs Remark
1 A F captive alive 44 pos >50 2002–2014 EEHV1B - 2007/2008 O/V subclinical ref [17]
1 A1 F captive alive 14 pos >50 2002–2014 EEHV1B - 2007 O subclinical ref [17]
1 C F wild alive 28 border >50 2002–2012 EEHV1B - 2008 O subclinical ref [17]
1 D F captive alive 12 ND >50 2013–2014 EEHV1B - 2008 O subclinical ref [17]
1 E M captive alive 17 pos 2 2013–2014 EEHV1 - 2014 TW/C subclinical
2 A M captive alive 23 ND >50 2006–2013 not detected
2 B F wild alive 31 border >50 2006–2013 EEHV5 -2011 TW subclinical
2 B1 M captive alive 10 pos 40–50 2006–2011 EEHV1A - 2008/2011 WB subclinical
2 B2 M captive dead 1 pos 3 2006–2013 EEHV1A - 2009 necropsy fatality
2 B3 M captive alive 3 pos 8 2012–2013 EEHV1 - 2013 WB clinically ill 2013
2 C F wild alive 33 ND 40–50 2006–2013 EEHV1A - 2011 TW subclinical negative
study control
2 D F wild alive 33 border 40–50 2006–2013 not detected nd healthy
2 E F captive alive 32 pos >50 2006–2013 EEHV1A - 2011 TW subclinical
2 E1 F captive dead 2 pos 3 2006 EEHV1B - 2006 necropsy fatality ref [14]
2 E2 F captive dead 2 pos 3 2006–2013 EEHV1A - 2009 necropsy fatality
2 E3 F captive alive 5 pos >50 2006–2013 EEHV1A - 2011 TW subclinical
2 F F captive alive 16 ND >50 2006–2013 EEHV1A - 2011 U/V subclinical
2 F1 M captive alive 5 pos 20 2011–2013 EEHV1A - 2011 TW subclinical
3 A F captive alive 19 ND 40–50 2007–2012 not available
3 B F wild alive 30 pos 40–50 2006–2012 not available
3 C F wild alive 30 border 20 2012 not available
3 C1 F captive alive 16 border 20 2012 not available
4 A M captive alive 9 pos 2 2007–2014 not done positive
study control
5 A F wild alive 29 pos 1 2002 not done positive
study control
Zoos are numbered, elephants are indicated with a letter and subsequent numbers describe maternal offspring
ND, not detectable
TW, trunk wash
C, conjunctiva
U, urine
O, oral lesion
WB, whole blood
V, vulva
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blot using an anti-6His tag mouse monoclonal antibody
(Clontech). As a secondary antibody goat anti-mouse
IRdye680 (Licor) was used.
Rabbit serum reactivity with recombinant glycoprotein
B was detected with Western Blot by incubating the
membranes with rabbit serum (1:400 dilution) followed
by detection with goat-anti-rabbit IRdye680 (Licor).
Similar strategy was done for elephant serum (1:1000
dilution), but primary antibody was detected with rabbit-
anti Asian elephant IgG (1:1000 dilution). Sera of rab-
bits as well as elephants were pre-incubated in buffer
containing E.coli lysate (~3 μg/ml) for 1 h at room
temperature in order to reduce possible E.coli reactiv-
ity. The signal of the conjugate was detected with the
Licor Odyssey scanner (Licor).
Glycoprotein B specific capture ELISA
To avoid non-specific reaction against E.coli contami-
nants which co-purified with the 6His-tagged EEHV gB
antigen during Ni-NTA purification an optimal concen-
tration of 100 ng/well of mouse-anti 6His antibody (Clon-
Tech) as a capture antibody was coated in high binding
96-well microtiterplate (Costar). The microtiter plates
were blocked with 100 μl/well of PBS containing 2 % w/v
BSA in PBS for one hour at 37 °C and washed. All wash-
ing steps were performed three times with 200 μl of wash
buffer (PBS + 0.05 % v/v Tween20). To determine the op-
timal antigen concentration for use in the ELISA, the gB
antigen was diluted two-fold starting at 2400 ng per well.
A pool of rabbit sera was used as anti-gB positive serum.
The purified EEHV-gB antigen was diluted in PBS
containing 0.1 % Triton-X to a concentration of 750 ng/
well and bound to the capture antibody for 1 h at 37 °C.
After washing, primary incubation was performed with
100 μl/well diluted (1:100 and 1:200) elephant serum in
ELISA buffer containing PBS, 0.2 % BSA, 0.1 % non-fat
dried powder milk and 3 % w/v NaCl and incubated for
one hour at 37 °C. After washing, elephant specific IgG’s
bound to glycoprotein B were detected by incubation with
100 μl/well of rabbit anti-elephant IgG (1:1000 diluted in
ELISA buffer) for one hour at 37 °C followed by an incuba-
tion step with swine anti-rabbit IgG HRPO conjugate
(1:1000 diluted in ELISA buffer). After washing 100 μl/
well 1xTMB substrate (KPL laboratories) was added, in-
cubated for 10 min at room temperature. The reaction
was stopped by adding 100 μl 0.5 M H2SO4 per well. The
absorbance (OD) was measured at 450 nm with 620 nm
reference filter (A450/620) on a 96-well plate spectrophotom-
eter (Tecan).
Study cohort in Europe/USA
The elephants in this study were kept in zoos as part
of the European Endangered Species Program (EEP,
Europe) and the Species Survival Program (SSP,USA).
Within these programs elephants are trained to allow
voluntarily blood collection for several reasons: moni-
toring health parameters, monitoring reproduction pa-
rameters and providing (retrospective) data for new
diagnostic technologies for diseases that may threaten
their health. The use of banked elephant blood samples
for a retrospective research study falls within the law.
All participating zoos reviewed and approved the re-
search proposal for this study and allowed the use of
their banked elephant blood samples.
All elephants in the study were Asian elephants;
Table 1 (Asian elephants located in Europe) and 2 (Asian
elephants located in North America) summarize the age,
sex, and clinical status of elephants which will be dis-
cussed in detail in this study. All participating zoos
reviewed and approved the research described in this
study. Initially, 831 serum or heparin plasma samples of
125 Asian elephants located in 14 European zoos were
tested for validation of the capture ELISA test. The cut-
off value was calculated as a mean OD of 37 samples of
19 animals which scored consistently on the base line
level of the test.
Three European zoos (Zoo 1, 2 and 3) provided Asian
elephant serum or plasma samples for a longitudinal
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Fig. 1 SDS-PAGE total protein analysis (panel a) and Western blot
analysis with an anti-His monoclonal antibody (panel b) demonstrate
the purification of full length EEHV-gBHis (~87 kD) and several
smaller fragments with a his-tag produced from the EEHV-gBHis
open reading frame (lane EL, eluate). During purification a small
portion of the recombinant protein is lost in the flow through of the
NiNTA column (lane FT) and during the washing steps (lane W1-2, W3-4,
W5-6). The empty vector does not yield any his-tagged proteins (lane
UT). Lane M is the molecular weight marker
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Fig. 3 E. coli protein contamination in the purified antigen (Ag) induces background signal in an indirect ELISA (panel a). This background is
reduced in a sandwich ELISA using a mouse monoclonal anti-his antibody as a capture antibody for the target antigen (panel b-d). Pooled EEHV-gB
peptide specific rabbit serum was used in a 1:200 dilution. Panel A no capture antibody, panel B 100 ng capture antibody, panel c 200 ng capture antibody,
panel D 300 ng capture antibody
1 3 1 3 1 3
60 kD
50 kD
40 kD
30 kD
100 kD
80 kD
M M M
A B C
anti-6His anti-EEHV gB serum elephant 4A
2 22
Fig. 2 Western blot analysis of an irrelevant 27 kD his-tagged protein and (lane 1), single NiNTA purified EEHV-gBHis (lane 2) and double purified NiNTA/
HisTrap FPLC (lane 3) with three different antisera. a Western blot with mouse monoclonal anti-His demonstrates the 27 kD His-tagged protein in lane 1
and the highly fragmented EEHV-gBHis in lane 2 and 3. Double purification results in loss of the full length EEHV-gBHis (lane 3). bThe rabbit peptide
(ANVTSRRRKRDANTA) EEHV-gB specific antiserum recognizes non-his tagged bands. c Serum of elephant 4A detects identical bands as the rabbit peptide
specific serum in the EEHV-gBHis recombinant protein, except for the ~32 kD band which might be an E.coli background band (panel b)
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seroprevalence study ranging from 250 up to 600 days for
multiple animals in their herds. Moreover, the samples
from Zoo 1 and 2 (including trunkwash and conjunctiva
swabs) were also analyzed for EEHV presence by qPCR.
In the USA cohort 476 Asian elephant samples were
tested from 63 animals in 17 zoos in the period 2006
until 2012 with a six month interval.
All samples were tested in 1:100 and 1:200 dilutions
and the signal to background OD was calculated for
both dilutions. A sample was considered positive when
both dilutions produced ODs 3 times of the back-
ground OD and undetectable when both dilutions pro-
duced less than 2 times the background OD. A sample
was considered as borderline when one or both dilu-
tions measured an OD between 2–3 times the back-
ground OD values.
An animal was considered to be seropositive when all
analyzed samples scored positive with an occasional
borderline score. An animal was considered borderline
seropositive when the majority of its samples scored bor-
derline. An animal was considered undetectable when all
of its samples were undetectable.
Results
Expression and purification of EEHV glycoprotein B
Positioning of the EEHV-gB open reading frame (ORF)
in an alternative position downstream of the Shine
Dalgarno ribosomal binding site (RBS) severely reduced
the expression levels of the recombinant EEHV-gB, but
retained the recombinant protein in the soluble fraction
and in its native conformation. Purification of the re-
combinant EEHV-gB was performed using nickel col-
umns (Fig. 1). Full length EEHV-gB has an expected
molecular size of 87 kD, and a band at this expected size
was observed (Fig. 1b). Since the portion of recombinant
gB protein in the E.coli lysate was low many native pro-
teins of E. coli Rosetta2 that displayed affinity to nickel in
the Immobilized Metal Affinity Chromatography (IMAC)
were co-purified during Ni-NTA purification. Full length as
well as many other molecular weight sizes, were detected
by anti-6His-tag antibody detection on Western Blot. West-
ern blot analysis with the EEHV-gB peptide specific rabbit
(ANVTSRRRKRDANTA) serum showed more bands with
different molecular weights compared to the pattern ob-
tained with anti-his antibody (Fig. 2a and b). Several spe-
cific smaller bands were also detected. An elephant serum,
which did contain EEHV-gB specific antibodies, as detected
with the described sandwich ELISA, did not recognize as
many of the EEHV-gB fragments on Western blot (Fig. 2c).
Since the double purified (Ni-NTA followed by FPLC
Histrap) lost a portion of the full length EEHV-gB (Fig. 2a)
the single Ni-NTA purified antigen was further used to
develop an ELISA test.
Validation of an EEHV glycoprotein B specific capture
ELISA
To reduce aspecific E.coli protein reactivity (Fig. 3a)
the ELISA assay was setup as a capture ELISA using a
mouse-anti 6His monoclonal antibody. Pooled sera of
rabbits immunized with EEHV-specific peptides were
used as a positive control. Figure 3 shows that 100 ng
of the capture antibody reduces aspecific reactivity to
an acceptable background level of an A450/620 of ~0.2.
Subsequently, the capture ELISA was further validated
with an antigen checkerboard titration to test its spe-
cificity with various irrelevant rabbit sera. The results
in Fig. 4 demonstrate a dose-related response only when
EEHV-gB specific sera were used. Irrelevant rabbit antisera
did not react with the antigen. To detect antibody reactivity
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Fig. 5 Characterization of the sandwich ELISA with elephant sera. Elephant sera react in a dose-dependent manner as shown by antigen titration
(panel a) and are specific for the EEHV-gB antigen only (panel b)
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Fig. 4 Specificity of the EEHV-gB sandwich ELISA was determined by
antigen titration with the EEHV-gB peptide specific rabbit serum,
one serum of an EEHV1 PCR positive elephant and two irrelevant
rabbit sera. All sera were diluted 1:200 in ELISA buffer
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in the linear range an optimum of 750 ng antigen/well was
used in the ELISA, which was used to evaluate the elephant
sera cohorts. Once the capture ELISA was developed with
the EEHV-gB specific rabbit sera, a large panel of ele-
phant sera was tested to screen for sera with specific re-
activity. In total 831 serum or plasma samples of Asian
elephants, representing 125 animals of 14 zoos were
tested. Twenty-three animals from 7 zoos tested consist-
ently positive (18 %), 24 animals of 5 zoos tested inter-
mittently positive/borderline/undetectable (19 %) and 78
animals tested consistently undetectable (63 %). The test
was repeated twice in separate experiments and the re-
sults were reproducible. We found three sera with
extremely high reactivity in the capture ELISA (elephant
2B1, 4A and 5A respectively, Table 1) and several non-
reactive sera (lowest responder was elephant 2C). These
elephant sera were used to test again the antigen dose
and specificity (Fig. 5). The sera of elephant 2B1, 4A and
5A showed a dose-dependent reactivity whereas the
serum from elephant 2C did not (Fig. 5a). Serial dilutions
of serum of animal 5A (positive serum) and animal 2C
(undetectable serum) on EEHV-gB antigen or an irrele-
vant 6His-tagged protein were used in the assay to test
the specificity. Only the positive serum of animal 5A
reacted in a dose-dependent manner with EEHV-gB anti-
gen and not with the irrelevant antigen (Fig. 5b).
Table 2 age, sex, and clinical EEHV status of elephants in the study cohort of USA zoos
Zoo Animal Sex Born Status Age Serostatus Sample # Period PCR detection Detection
site
Clinical signs Remark
1 A M wild alive 50 ND 13 2006–2012 EEHV5A (2011) TW subclinical
1 B F wild alive 46 border 13 2006–2012 EEHV1B (2009)/
EEHV5(2011)
WB Lethargic ref [23, 24]
1 C F wild alive 34 ND 9 2008–2012 EEHV1A-(2009)/
EEHV5B (2011)
TW subclinical ref [15]
1 C1 M captive alive 10 ND 9 2008–2012 EEHV1A/EEHV1B/
EEHV5B
TW/WB subclinical ref [15, 23]
1 C2 F captive alive 4 pos 2 2012 EEHV5A (2011) TW Subclinical ref [15]
2 D F captive alive 24 pos 13 2006–2012 EEHV1A(2009)/
EEHV1B (2010)
TW/WB 2010 Subclinical ref [12,
19, 24]
2 D1 M captive alive 5 pos 2 2010–2012 EEHV5A (2011) TW/WB Temporal
gland swelling
ref [15]
2 A F wild alive 44 pos 11 2006–2011 not detected
2 B F wild alive 44 ND 12 2006–2011 not detected
2 B1 M captive alive 22 pos 11 2006–2011 not detected
2 C F wild alive 44 ND 11 2006–2011 not detected ref [19]
2 C1 F captive alive 8 pos 6 2009–2011 EEHV1A (2010)/
EEHV1B (2009)
WB/TW subclinical
feb/dec 2009
ref [19]
2 D F wild alive 35 pos 11 2006–2011 not detected
2 E F captive alive 18 pos 11 2006–2011 not detected
2 E1 F captive alive 8 pos 5 2009–2011 EEHV1A/EEHV1B
(2009)
WB/TW clinically ill
feb/dec 2009
ref [19]
2 A F wild alive 45 pos 7 2006–2010 not available
2 B F wild alive 44 pos 7 2006–2010 not available
2 B1 F captive alive 16 pos 7 2006–2010 not available
3 C F wild dead 41 border 4 2006–2007 not available
3 D F captive alive 26 pos 7 2006–2010 not available
3 A F wild alive 48 border 10 2006–2011 not done
3 B F wild alive 41 border 9 2006–2011 not done
4 B1 F captive alive 22 pos 10 2006–2011 not done
5 B1-1 F captive alive 5 pos 1 2010 not detected
1 C M captive alive 17 pos 10 2006–2011 not detected
1 D M captive alive 16 pos 7 2006–2009 not detected
Zoos are numbered, elephants are indicated with a letter and subsequent numbers describe maternal offspring
ND, not detectable
TW, trunk wash
C, conjunctiva
U, urine
O, oral lesion
WB, whole blood
V, vulva
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The majority of EEHV PCR positive elephants display
EEHV specific antibodies
For 36 animals (Table 1 and 2) EEHV PCR data was avail-
able, either from published data [12, 14, 15, 17, 19, 23, 24]
or personal communications. We compared these results
with our ELISA results. Nineteen out of 25 PCR positive
animals (76 %) displayed antibodies, of which 16 had sig-
nificant antibody titers and three had borderline titers.
However, in six out of 25 animals no EEHV specific anti-
bodies could be detected (elephants 1D, 2C, 2 F, 6A, 6C,
6C1) while they had been tested positive with the EEHV
specific PCR. Eight elephants displayed EEHV-gB specific
antibodies, but never tested positive in a routine PCR (ele-
phant 2D, 7A, 7B1, 7D, 7E, 9B1-1, 9C and 9D). Four ani-
mals were EEHV5 PCR positive of which three displayed
antibodies against EEHV-gB.
Seroprevalence of a European study cohort
Three European zoos were approached to collaborate in
our study; their animals are listed in Table 1 (zoo 1 to 3)
and their Asian elephant sera collections were analyzed
over a substantial period of time (600 days Zoo 1, 400 days
Zoo 2 and 250 days Zoo 3). During the study period the
animals of Zoo 1 and 2 were screened for EEHV virus
presence in whole blood, trunk wash and conjunctiva
swabs by either conventional or real time PCR. Figure 6
displays the serostatus of these three herds; the observed
patterns showed a rise-and-fall in signal to background ra-
tios (thus, relative antibody quantity). A similar rise-and-
fall pattern was observed for animals, which scored below
the detection level. Additional clinical evaluations of the
animals in this study can be found in (Additional file 1).
Only two animals had a positive PCR in the study-
period in either trunk wash (animal 1A) or whole blood
(animal 2B3). As seen in Fig. 6a animal 1A was EEHV1
PCR positive in trunk wash on day 150 and, shortly
afterwards, had elevated antibody titers up to 8 weeks
after the PCR positive trunk wash. As shown in Fig. 6b
calf 2B3 developed a DNAemia and clinical signs of
EEHV disease on day 370 of the study period with typ-
ical EEHV clinical signs. However, this calf was already
seropositive on day 90 of the study period. He survived
this episode with supportive treatment and famciclovir
administration. Eighteen days prior to disease onset his
half-sister 2E3 showed a rise in antibody titers. Unfortu-
nately no samples of the other herd members were avail-
able in this period of the study.
Discussion
To date, an accurate and dependable test to evaluate
EEHV seroprevalence in Asian elephants has not been
developed. In part, this is due to the inability to culture
the virus in vitro and therefore whole virus is not avail-
able as the ideal antigen source for an ELISA.
Production of recombinant proteins from one of the
EEHV glycoproteins, like gB, has proven to be a major
challenge. Here we describe a novel ELISA that specific-
ally detects EEHV-gB antibodies circulating in Asian ele-
phants. We were able to link seroprevalence to PCR
detection of the EEHV in approximately 80 % animals.
This novel assay will provide more insight into the epi-
demiology of this hitherto poorly understood virus.
The antigen expression, production and purification
methods for fragmented EEHV-gB (genotype 1A) driven by
a bacterial Shine Dalgarno promoter in an alternative open
reading frame, yielded antigens for a sandwich ELISA spe-
cific for EEHV-gB. Incomplete EEHV-gB amino acid
Fig. 6 Serostatus of three European zoos measured as the signal to
background ratio over a period of time. Zoo 1 (panel a) was studied
from October 2012 until April 2014. Zoo 2 (panel b) was studied from
May 2012 until May 2013 and Zoo 3 (panel c) from January 2012 until
September 2012. The arrow indicates a positive EEHV1 PCR of the trunk
wash (animal 1A) or whole blood (animal 2B3). Elephants with non-
detectable levels of EEHV antibodies are indicated in black, elephants
with an alternating serostatus in orange and elephants with continuous
anti-EEHV antibodies in red
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sequences were produced from the plasmid presumably
due to programmed ribosomal frameshifting (PRF) and al-
ternative translation initiation sites. PRF and alternative
translation initiation are well-described phenomena [25–
28] and can occur in prokaryotes, as well as in eukaryotes.
PRF occurs when the ribosome encounters a so-called hun-
gry codon (low level of acetylated tRNA) in its A-site
followed by a slippery sequence in the P-site of the riboso-
mal complex. In our expression system, it is likely that the
Shine Dalgarno sequence RBS initiates the overexpression
of a short nonsense peptide of 36 amino acids thereby re-
leasing the ribosomes quickly in order to re-initiate transla-
tion with a high likelihood to undergo PRF since this small
ORF contains multiple hungry codons. As a side product,
fragments of EEHV-gB specific sequences, either with or
without a his-tag were made and confirmed by Western
blot analysis. This suggested that the non-his-tagged frag-
ments were co-purified during the purification process.
EEHV-gB peptide specific rabbit sera were able to detect
the antigen fragments, whereas positive elephant sera rec-
ognized fewer of these fragmented antigen products. It is
likely that the majority of the anti-EEHV-gB antibodies in
elephants recognize conformational epitopes, which are lin-
earized in Western Blot. This is supported by the fact that
the produced antigen was highly reactive in the sandwich
ELISA test with the positive rabbit sera as well as many ele-
phant sera and not with irrelevant sera. As a result, it is
likely that this ELISA would fail to detect antibodies di-
rected to those conformational epitopes of gB which do not
form properly in the bacterial expression machinery. In this
study no seronegative elephants were found. The back-
ground of the described assay was set up with sera of
elephants, which were consistently found on the non-
detectable range of the assay, but still ~0.1 OD higher
than naïve rabbit serum. This test was developed with a
capture antibody, which did not completely reduce the
background to an OD of 0. Therefore, it is highly likely
that the cut-off value was leveled unrealistically high. In
the study cohort we found several seropositive elephants,
which were routinely diagnosed with other subtypes than
EEHV1A by PCR. The obtained data suggest that this test
may be able to detect antibodies against gB from EEHV
subtypes other than EEHV1A; at least EEHV1B and
EEHV5. Divergence on the amino acid level of the glyco-
protein B of the subtypes EEHV ranges from 11 %
(EEHV1A vs EEHV1B) up to 21 % (EEHV1A vs EEHV5)
[23]. However, we cannot exclude that these animals did
had an EEHV1A co-infection as well. It is interesting to
speculate that genetic background plays a role in suscepti-
bility to develop severe disease. However, better designed
study cohorts, which include serology as well as PCR de-
tection of the virus are required in order to address the
question whether the host genetic background has a major
role in fatal EEHV disease.
Conclusion
We have shown that it is possible to express the gB of
EEHV in a bacterial system by using alternative transla-
tion upstream of the Shine Dalgarno sequence. Further,
our results and those of recent reports [15, 17, 19, 29]
demonstrate that EEHV prevalence in captive born as
well as wild-born elephants (as measured by virus detec-
tion with PCR techniques in whole blood and trunk se-
cretions) is much higher than initially anticipated. These
studies underline that elephants may be the natural host
of EEHV that, in general, does not cause major disease.
The methodology and data presented in this article give
a novel insight into the EEHV1 seroprevalence in Asian
elephants. As expected, a large portion of elephants
showed antibodies against EEHV, but not all. Addition-
ally, the serostatus of elephants within a herd may vary
from non-detectable up to high titers.
Additional file
Additional file 1: Supplementary information. (DOCX 125 kb)
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